Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Actuate Therapeutics Inc.
Hoffmann-La Roche
Erasca, Inc.
National Cancer Institute (NCI)
UMC Utrecht
Memorial Sloan Kettering Cancer Center
Cogent Biosciences, Inc.
Institut National de la Santé Et de la Recherche Médicale, France
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Institut Bergonié
Sensei Biotherapeutics, Inc.
Immunophotonics, Inc.
Centre Leon Berard
Adaptimmune